Status:
COMPLETED
Decision Support for BRCA Testing in Ethnically Diverse Women
Lead Sponsor:
Columbia University
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Breast Cancer
BRCA1 Mutation
Eligibility:
FEMALE
21-75 years
Phase:
NA
Brief Summary
The objective of this study is to expand genetic testing for hereditary breast and ovarian cancer syndrome to a broader population of high-risk women by prompting appropriate referrals from the primar...
Detailed Description
Hereditary breast and ovarian cancer syndrome (HBOC) is an inherited condition that is most commonly associated with mutations in the BRCA1 and BRCA2 genes. Mutation carriers have lifetime risks of br...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Patient Participants):
- Women, age 21-75 years
- Meets criteria for genetic testing based on family history
- Sees a primary care provider in the Columbia University (CUMC) /New York Presbyterian (NYP) Ambulatory Care Network
- Understands as is willing to provide informed consent in English or in Spanish
- Exclusion Criteria (Patient Participants):
- Prior genetic counseling or testing for hereditary breast and ovarian cancer (HBOC)
- A personal history of breast or ovarian cancer
- Inclusion Criteria (Health Care Provider Participants):
- Primary care providers, such as attending physicians, residents, nurse practitioners, physician assistants, and midwives, who see patients at CUMC/NYP Ambulatory Care Network clinics
- Able to provide informed consent
Exclusion
Key Trial Info
Start Date :
December 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2020
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT03470402
Start Date
December 13 2017
End Date
August 17 2020
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032